Acute Decompensation of Pulmonary Hypertension

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

December 12, 2022

Study Completion Date

December 16, 2022

Conditions
Hypertension, PulmonaryBiomarkers
Interventions
OTHER

A biobank will be created from blood samples taken at admission, days 3 and days 7

A biobank will be created from the blood samples taken on admission, days 3 and 7 of admission. The prognostic value of the preselected biomarkers will be analyzed and a proteomic analysis will be performed to identify new biomarkers. The prognostic value of these new biological parameters will be compared to the usual surveillance parameters that will be collected during the follow-up (clinical, echocardiographic and hemodynamic parameters)

Trial Locations (1)

94270

SAVALE Laurent, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03926572 - Acute Decompensation of Pulmonary Hypertension | Biotech Hunter | Biotech Hunter